On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Prevalence of hypertension by BMI and AGE
- Abdominal obesity and blood presure
- Obesity and MI: case control study
- BMI categories with MI risk: waist-to-hip ratio
- Obesity and cardiovascular risk
- Vital statistic: waist circumference
- Pathophysiology of obesity hypertension
- Hemodynamic alterations in obese adolescents
- High fat diet causes Na retention and hypertension
- Leptin acts as a lipostat
- Carotid artery leptin infusion decreases food intake
- Leptin infusion increases arterial pressure
- Leptin in obese normotensives and hypertensives
- Leptin and sympathetic nerve activity
- Cardiorenal effects of obesity
- Renin-angiotensin system in obesity
- Renin-angiotensin genes expression in adipocytes
- AT1 receptor expression on human adipocytes
- Meta-Analysis of RCTs
- Antihypertensive agents in obese hypertensives
- Treatment of obesity hypertension
- Trial of hypertension prevention of weight-loss arm
- Currently approved antiobesity agents
- Orlistat promotes clinically significant weight loss
- Orlistat: effect on blood pressure in hypertensives
- Study: sibutramine in obese hypertensive patients
- Reality: CV side effects in sibutramine trials
- BP changes in sibutramine-treated patients
- Sympathetic stimulation: handgrip test
- Sympathetic stimulation: cold pressor test
- Plasma noradrenaline: supine
- Sibutramine affects sympathetic activity
- Sibutramine: Scout study
- Bariatric surgery: effect on cardiovascular risk
- Summary and Conclusions
Topics Covered
- Prevalence of hypertension
- Abdominal obesity and blood pressure
- Myocardial infarction risk
- Obesity and cardiovascular risk
- Pathophysiology of obesity hypertension
- Leptin
- Cardiorenal effects of obesity
- Renin-angiotensin system in obesity
- Treatment of obesity hypertension
- Currently approved anti-obesity agents: Orlistat and Sibutramine
- Bariatric surgery
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Sharma, A. (2007, October 1). Pathophysiology and management of obesity related hypertension [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 19, 2025, from https://doi.org/10.69645/XAQU8193.Export Citation (RIS)
Publication History
- Published on October 1, 2007
Financial Disclosures
- Prof. Arya Sharma has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Pathophysiology and management of obesity related hypertension
Published on October 1, 2007
23 min